Cancer Genomics
Por:
Fonseca-Montaño M.A., Blancas S., Herrera-Montalvo L.A., Hidalgo-Miranda A.
Publicada:
1 ene 2022
Categoría:
Medicine (miscellaneous)
Resumen:
In the past decade, genomics has fundamentally changed our view of cancer biology, allowing comprehensive analyses of mutations, copy number alterations, structural variants, gene expression and DNA methylation profiles in large-scale studies across different cancer types. Efforts like The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) have fostered international collaborations for cancer genomic analyses and have generated public databases that give scientists around the world access to thoroughly curated data, which have been extensively used as a tool for further hypothesis driven research on several aspects of cancer biology. In parallel, some of these findings are being translated into specific clinical benefits for cancer patients. In this review, we provide a brief historical description of the evolution of international public cancer genome projects and related databases, as well as we discuss about their impact on general cancer research. © 2022
Filiaciones:
Fonseca-Montaño M.A.:
Instituto Nacional de Medicina Genómica, Ciudad de Mexico, Mexico
Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Ciudad de México, Mexico
Blancas S.:
Instituto Nacional de Medicina Genómica, Ciudad de Mexico, Mexico
Cátedras Consejo Nacional de Ciencia y Tecnología, Ciudad de México, Mexico
Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Ciudad de México, Mexico
Herrera-Montalvo L.A.:
Instituto Nacional de Medicina Genómica, Ciudad de Mexico, Mexico
Hidalgo-Miranda A.:
Instituto Nacional de Medicina Genómica, Ciudad de Mexico, Mexico
Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Ciudad de México, Mexico
All Open Access; Hybrid Gold Open Access
|